Organon Zemuron Shortage Continues
This article was originally published in The Pink Sheet Daily
Executive Summary
Supplies of Organon's Zemuron (rocuronium) will not return to normal until the fall, according to the Center for Drug Evaluation & Research's website
You may also be interested in...
Organon Pharma Focus Is "Short Term": Strategic Decisions Later
Akzo Nobel wants to "fix pharma first" before it makes any decisions about long-term strategy in Rx sector, company says. Sales of Follistim are being held back by supply problems following shutdown of West Orange, N.J. plant.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.